Medicenna Therapeutics (MDNA) Stock News

MDNA Nasdaq

11/09/2023 08:56 AM

News

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

14.54%

Tags

-

11/06/2023 07:00 AM

News

Medicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

22.52%

Tags

-

11/03/2023 12:00 PM

News

Medicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

48.02%

Tags

10/27/2023 07:55 AM

News

Medicenna Announces Nasdaq Delisting and Cutback of Management Team

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-21.24%

Tags

-

10/25/2023 07:00 AM

News

Medicenna Therapeutics Doses First Patient in Phase 2 Monotherapy Dose Expansion Portion of the ABILITY Study Evaluating MDNA11 in Select Types of Solid Tumors

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-5.04%

Tags

-

10/24/2023 07:15 AM

News

Medicenna Announces Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer’s (SITC)

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2.84%

Tags

10/10/2023 07:07 AM

News

Medicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.2%

Tags

-

10/03/2023 07:00 AM

News

Medicenna Presents Preclinical MDNA223 BiSKIT Data at the AACR Special Conference on Tumor Immunology and Immunotherapy

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.21%

Tags

-

09/28/2023 05:00 PM

News

Medicenna Announces Results of Annual and Special Meeting of Shareholders

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.7%

Tags

09/28/2023 07:00 AM

News

Medicenna to Present at the AACR Special Conference Cancer Research: Tumor Immunology and Immunotherapy

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-5.42%

Tags